Paul Heldman

Mr. Paul Heldman is an Equity Research Analyst at Nephron Research LLC.
Mr. Heldman has over 20 years of experience in health policy and specializes in translating legislative developments and policy changes – specifically for government health insurance programs, the FDA, pharmaceuticals, medical devices, US health spending, healthcare legislation, and national elections.
Prior to joining Nephron, Mr. Heldman co-cofounded Heldman Simpson Partners LLC, and ran the healthcare team at Potomac Research Group.
He previously spent a combined eight years at Citigroup Investment Research and Schwab Soundview Washington Research Group.
He holds a BA from Clark University.